Eirin Alfonso, Zhang Xin, Zhu Xiang-Yang, Tang Hui, Jordan Kyra L, Grande Joseph P, Dietz Allan B, Lerman Amir, Textor Stephen C, Lerman Lilach O
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Nephrol Dial Transplant. 2014 Feb;29(2):274-82. doi: 10.1093/ndt/gft305. Epub 2013 Oct 3.
Renal parenchymal inflammation is a critical determinant of kidney injury in renal artery stenosis (RAS) but is difficult to assess in the single kidney without tissue samples. Whether renal vein (RV) levels of inflammatory markers reflect active parenchymal inflammation remains unknown. We evaluated the relationship between net RV cytokine release and tissue inflammation in the post-stenotic kidney.
Pigs were studied after 10 weeks of RAS treated 4 weeks earlier with intra-renal vehicle or anti-inflammatory mesenchymal stem cells (MSCs) or normal control. Single-kidney renal blood flow was measured by fast computerized tomography. RV and inferior vena cava levels of tumor necrosis factor (TNF)-α, interferon (IF)-γ, monocyte chemoattractant protein (MCP-1) and interleukin (IL)-10 were measured by enzyme-linked immunosorbent assay, and their net release calculated. Renal expression of the same cytokines was correlated with their net release.
Net release of TNF-α, IF-γ and MCP-1 was higher in RAS compared with normal and to the contralateral kidney (all P<0.05), decreased in MSC-treated pigs as was their tissue expression. Contrarily, the release of the anti-inflammatory IL-10 was lower in RAS and normalized in RAS+MSC. The net release of TNF-α, MCP-1 and IL-10 directly correlated with their tissue expression. The ratio of inflammatory-to-reparative macrophages directly correlated with the release of MCP-1, but inversely with the release of IL-10. In vitro cultured MSCs also induced a shift in the macrophage phenotype from inflammatory (M1) to reparative (M2).
Our findings demonstrate that the release of inflammatory markers from the affected kidney provides an index of renal tissue inflammation in experimental RAS.
肾实质炎症是肾动脉狭窄(RAS)所致肾损伤的关键决定因素,但在无组织样本的单肾中难以评估。肾静脉(RV)中炎症标志物水平是否反映活跃的实质炎症尚不清楚。我们评估了狭窄后肾脏中肾静脉细胞因子净释放与组织炎症之间的关系。
对猪进行研究,这些猪在4周前接受了肾内载体或抗炎间充质干细胞(MSC)治疗或正常对照治疗10周后发生RAS。通过快速计算机断层扫描测量单肾肾血流量。采用酶联免疫吸附测定法测量肿瘤坏死因子(TNF)-α、干扰素(IF)-γ、单核细胞趋化蛋白(MCP)-1和白细胞介素(IL)-10在肾静脉和下腔静脉中的水平,并计算其净释放量。相同细胞因子的肾组织表达与它们的净释放相关。
与正常组和对侧肾脏相比,RAS组中TNF-α、IF-γ和MCP-1的净释放量更高(均P<0.05),在接受MSC治疗的猪中其净释放量和组织表达均降低。相反,抗炎性IL-10的释放在RAS组中较低,在RAS+MSC组中恢复正常。TNF-α、MCP-1和IL-10的净释放量与其组织表达直接相关。炎性巨噬细胞与修复性巨噬细胞的比例与MCP-1的释放直接相关,但与IL-10的释放呈负相关。体外培养的MSC也诱导巨噬细胞表型从炎性(M1)向修复性(M2)转变。
我们的研究结果表明,患肾中炎症标志物的释放为实验性RAS中的肾组织炎症提供了一个指标。